With the fast moving, ever-changing landscape of healthcare today, the mission of AJMC TV is to inform payers, clinical decision makers, and policy makers through brief video interviews providing the most recent and important information. Interviews with managed care professionals discussing breaking news on healthcare policy, study data, payer/provider relationships, and innovative payment models will be posted regularly. We hope you find these interviews informative, and encourage you to contribute comments to continue the discussion with your colleagues on these important managed care topics.
INTERVIEWS
Lee Newcomer, MD, MHA, of Oncology, Genetics and Women's Health for UnitedHealthcare, says the National Comprehensive Cancer Network is transforming genetic testing by utilizing a tool called the NCCN Biomarkers Compendium, which encourages evidence-based decision-making.
Edmund J. Pezalla, MD, MPH, national medical director, Aetna Pharmacy Management, says that Aetna recognizes the implications of the obesity epidemic and how it contributes to a variety of other medical problems such as diabetes and hypertension.
Christine Strahl, PharmD, MBA, BCPS, specialty pharmacy program manager, HealthPartners, says there are several new distribution channels in specialty pharmacy.
Amy Tenderich of DiabetesMine.com, a web-based news source for persons with diabetes, took part in panel discussions at “Patient-Centered Diabetes Care: Putting Theory into Practice,” sponsored by The American Journal of Managed Care.
Robert A. Gabbay, MD, PhD, chief medical officer and senior vice president, Joslin Diabetes Center, says that there are opportunities for treating diabetes within accountable care organizations (ACOs).
Peter B. Bach, MD, MAPP, director, Center for Health Policy and Outcomes, says accountable care organizations and patient-centered medical homes are trends driven by macro issues, which include decreased reimbursement to private practices and drug discounts from the 340B program.
Gary Liska, with Alere Home Monitoring Inc, says Alere’s commitment to patients’ safety is why they supported the STABLE study.